SeLux rakes in $25 mln Series B

Massachusetts-based-based SeLux Diagnostics, a developer of a next generation phenotyping platform, has raised $25 million in Series B financing, according to a source familiar with the transaction. Sands Capital Ventures led the round with participation from RA Capital Management, Schooner Capital and Northpond Ventures.

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!